DW

David Wu

Independent Director at Seraphina Therapeutics

San Francisco Bay Area

Overview 

David Wu is an Independent Board Director, Investor, and Musician based in the San Francisco Bay Area. He has made significant investments in companies like Booster, LIV, and Eargo, and serves on the boards of multiple organizations including Seraphina Therapeutics and the GRAMMY Museum. With a background in venture capital and strategic partnerships, David Wu has been instrumental in guiding companies like Wave and Illumix as a board member, while also contributing to the success of startups through his investments in sectors such as AR/VR, FinTech, and Consumer Internet.

Work Experience 

  • Venture Partner

    2022 - Current

  • General Partner

    2012 - 2022

  • Independent Director

    2024

    Manufacturer of Fatty15, the world’s first, and only science-backed, patented, award-winning C15:0 supplement that supports your long-term health & wellness.

Seraphina Therapeutics provides therapeutics services using natural products.

Raised $5,500,000.00 from Domain Associates and Murano Group.

  • Independent Director

    2024

    Compensation Committee.

  • Member, Board of Directors

    2022

    Nominations & governance committee, finance committee, audit committee, marketing committee, and GRAMMY Blue Ribbon Adjudication Committee.

  • Member, Board of Directors

    2020

    Compensation committee.

  • Member, Board of Directors

    2018

Illumix is an infrastructure solution that develops augmented reality games.

Raised $26,600,000.00 from Henry Kravis, Matthew Ball, Xavier Niel, Sony Innovation Fund, RW3 Ventures, Visible Ventures, OpenView, Mark Cuban and LightShed Ventures.

  • Member, Board of Directors

    2016

    Audit committee.

Booster is a fleet management company that specializes in delivering renewable fuels, gasoline, diesel, and bio-diesel delivery services.

Raised $213,612,016.00 from Madrona, Conversion Capital, Thayer Ventures, Cercano Management, Chaac Ventures, Mitsubishi Corporation, Invus Opportunities, Version One Ventures, Renewable Energy Group and Equinor Ventures.

  • Independent Director

    2013 - 2024

    Eargo went public (NASDAQ: EAR) in 2020. Audit committee chair, compensation committee, and special committee.

Eargo specializes in the design and development of hearing aids.

Raised $371,476,928.00 from Patient Square Capital.

  • Member, Board of Directors

    2021 - 2024

  • Member, Board Of Directors

    2017 - 2022

    Inkbox was acquired by BiC in 2022.

Articles About David

Relevant Websites